Detailed answers about THE BIOCENTRIC INVESTIGATIVE JOURNALISM CENTRE LTD, including incorporation, status, business activity, and accounts information.
When was THE BIOCENTRIC INVESTIGATIVE JOURNALISM CENTRE LTD founded?
THE BIOCENTRIC INVESTIGATIVE JOURNALISM CENTRE LTD was officially incorporated on 17 August 2026 and is registered under company number 17403946. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is THE BIOCENTRIC INVESTIGATIVE JOURNALISM CENTRE LTD?
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of THE BIOCENTRIC INVESTIGATIVE JOURNALISM CENTRE LTD?
THE BIOCENTRIC INVESTIGATIVE JOURNALISM CENTRE LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does THE BIOCENTRIC INVESTIGATIVE JOURNALISM CENTRE LTD do?
THE BIOCENTRIC INVESTIGATIVE JOURNALISM CENTRE LTD operates in the following sectors: 58190 - Other publishing activities, 85590 - Other education n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is THE BIOCENTRIC INVESTIGATIVE JOURNALISM CENTRE LTD's registered address?
The registered office address of THE BIOCENTRIC INVESTIGATIVE JOURNALISM CENTRE LTD is 1 Coldbath Square, London, England, EC1R 5HL. This is the official address filed with Companies House for legal and statutory correspondence.
Is THE BIOCENTRIC INVESTIGATIVE JOURNALISM CENTRE LTD financially stable?
Financial accounts for THE BIOCENTRIC INVESTIGATIVE JOURNALISM CENTRE LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.